Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation.

Garciaz S, N'guyen Dasi L, Finetti P, Chevalier C, Vernerey J, Poplineau M, Platet N, Audebert S, Pophillat M, Camoin L, Bertucci F, Calmels B, Récher C, Birnbaum D, Chabannon C, Vey N, Duprez E.

Clin Epigenetics. 2019 Oct 12;11(1):141. doi: 10.1186/s13148-019-0738-6.

2.

Nidogen-1 Contributes to the Interaction Network Involved in Pro-B Cell Retention in the Peri-sinusoidal Hematopoietic Stem Cell Niche.

Balzano M, De Grandis M, Vu Manh TP, Chasson L, Bardin F, Farina A, Sergé A, Bidaut G, Charbord P, Hérault L, Bailly AL, Cartier-Michaud A, Boned A, Dalod M, Duprez E, Genever P, Coles M, Bajenoff M, Xerri L, Aurrand-Lions M, Schiff C, Mancini SJC.

Cell Rep. 2019 Mar 19;26(12):3257-3271.e8. doi: 10.1016/j.celrep.2019.02.065.

3.

PLZF limits enhancer activity during hematopoietic progenitor aging.

Poplineau M, Vernerey J, Platet N, N'guyen L, Hérault L, Esposito M, Saurin AJ, Guilouf C, Iwama A, Duprez E.

Nucleic Acids Res. 2019 May 21;47(9):4509-4520. doi: 10.1093/nar/gkz174.

4.

TP53INP1 deficiency maintains murine B lymphopoiesis in aged bone marrow through redox-controlled IL-7R/STAT5 signaling.

Zidi B, Vincent-Fabert C, Pouyet L, Seillier M, Vandevelde A, N'guessan P, Poplineau M, Guittard G, Mancini SJC, Duprez E, Carrier A.

Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):211-216. doi: 10.1073/pnas.1809980116. Epub 2018 Dec 17.

5.

Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activity.

Koubi M, Poplineau M, Vernerey J, N'Guyen L, Tiberi G, Garciaz S, El-Kaoutari A, Maqbool MA, Andrau JC, Guillouf C, Saurin AJ, Duprez E.

Nucleic Acids Res. 2018 Apr 20;46(7):3339-3350. doi: 10.1093/nar/gky080.

6.

[The biological complexity of Polycomb group proteins: the case of EZH2].

Koubi M, Chabannon C, Duprez E.

Med Sci (Paris). 2017 May;33(5):499-505. doi: 10.1051/medsci/20173305013. Epub 2017 Jun 14. Review. French.

7.

The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia.

Jovanovic JV, Chillón MC, Vincent-Fabert C, Dillon R, Voisset E, Gutiérrez NC, Sanz RG, Lopez AA, Morgan YG, Lok J, Solomon E, Duprez E, Díaz MG, Grimwade D.

Leukemia. 2017 Mar;31(3):747-751. doi: 10.1038/leu.2016.338. Epub 2016 Nov 22. No abstract available.

PMID:
27872498
8.

PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progression.

Vincent-Fabert C, Platet N, Vandevelde A, Poplineau M, Koubi M, Finetti P, Tiberi G, Imbert AM, Bertucci F, Duprez E.

Blood. 2016 Apr 14;127(15):1881-5. doi: 10.1182/blood-2015-09-666974. Epub 2016 Mar 3.

PMID:
26941402
9.

The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells.

Mourgues L, Imbert V, Nebout M, Colosetti P, Neffati Z, Lagadec P, Verhoeyen E, Peng C, Duprez E, Legros L, Rochet N, Maguer-Satta V, Nicolini FE, Mary D, Peyron JF.

Leukemia. 2015 Oct;29(10):1993-2002. doi: 10.1038/leu.2015.112. Epub 2015 Apr 30.

PMID:
25925206
10.

Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.

Kühnl A, Valk PJ, Sanders MA, Ivey A, Hills RK, Mills KI, Gale RE, Kaiser MF, Dillon R, Joannides M, Gilkes A, Haferlach T, Schnittger S, Duprez E, Linch DC, Delwel R, Löwenberg B, Baldus CD, Solomon E, Burnett AK, Grimwade D.

Blood. 2015 May 7;125(19):2985-94. doi: 10.1182/blood-2014-12-613703. Epub 2015 Mar 24.

11.

Site- and allele-specific polycomb dysregulation in T-cell leukaemia.

Navarro JM, Touzart A, Pradel LC, Loosveld M, Koubi M, Fenouil R, Le Noir S, Maqbool MA, Morgado E, Gregoire C, Jaeger S, Mamessier E, Pignon C, Hacein-Bey-Abina S, Malissen B, Gut M, Gut IG, Dombret H, Macintyre EA, Howe SJ, Gaspar HB, Thrasher AJ, Ifrah N, Payet-Bornet D, Duprez E, Andrau JC, Asnafi V, Nadel B.

Nat Commun. 2015 Jan 23;6:6094. doi: 10.1038/ncomms7094.

12.

PcG methylation of the HIST1 cluster defines an epigenetic marker of acute myeloid leukemia.

Tiberi G, Pekowska A, Oudin C, Ivey A, Autret A, Prebet T, Koubi M, Lembo F, Mozziconacci MJ, Bidaut G, Chabannon C, Grimwade D, Vey N, Spicuglia S, Calmels B, Duprez E.

Leukemia. 2015 May;29(5):1202-6. doi: 10.1038/leu.2014.339. Epub 2014 Dec 8. No abstract available.

PMID:
25482132
13.

Epigenetics in focus: pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents.

Santini V, Melnick A, Maciejewski JP, Duprez E, Nervi C, Cocco L, Ford KG, Mufti G.

Crit Rev Oncol Hematol. 2013 Nov;88(2):231-45. doi: 10.1016/j.critrevonc.2013.06.004. Epub 2013 Jul 7. Review.

PMID:
23838480
14.

A hypomorphic mutation in the Gfi1 transcriptional repressor results in a novel form of neutropenia.

Ordoñez-Rueda D, Jönsson F, Mancardi DA, Zhao W, Malzac A, Liang Y, Bertosio E, Grenot P, Blanquet V, Sabrautzki S, de Angelis MH, Méresse S, Duprez E, Bruhns P, Malissen B, Malissen M.

Eur J Immunol. 2012 Sep;42(9):2395-408. doi: 10.1002/eji.201242589.

15.

Characterisation of genome-wide PLZF/RARA target genes.

Spicuglia S, Vincent-Fabert C, Benoukraf T, Tibéri G, Saurin AJ, Zacarias-Cabeza J, Grimwade D, Mills K, Calmels B, Bertucci F, Sieweke M, Ferrier P, Duprez E.

PLoS One. 2011;6(9):e24176. doi: 10.1371/journal.pone.0024176. Epub 2011 Sep 20.

16.

MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells.

Sarrazin S, Mossadegh-Keller N, Fukao T, Aziz A, Mourcin F, Vanhille L, Kelly Modis L, Kastner P, Chan S, Duprez E, Otto C, Sieweke MH.

Cell. 2009 Jul 23;138(2):300-13. doi: 10.1016/j.cell.2009.04.057.

17.

The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation.

Boukarabila H, Saurin AJ, Batsché E, Mossadegh N, van Lohuizen M, Otte AP, Pradel J, Muchardt C, Sieweke M, Duprez E.

Genes Dev. 2009 May 15;23(10):1195-206. doi: 10.1101/gad.512009.

18.

Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation.

Iwasaki H, Somoza C, Shigematsu H, Duprez EA, Iwasaki-Arai J, Mizuno S, Arinobu Y, Geary K, Zhang P, Dayaram T, Fenyus ML, Elf S, Chan S, Kastner P, Huettner CS, Murray R, Tenen DG, Akashi K.

Blood. 2005 Sep 1;106(5):1590-600. Epub 2005 May 24.

19.

A new role for C/EBPbeta in acute promyelocytic leukemia.

Duprez E.

Cell Cycle. 2004 Apr;3(4):389-90. Epub 2004 Apr 1.

PMID:
14976428
20.

C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.

Duprez E, Wagner K, Koch H, Tenen DG.

EMBO J. 2003 Nov 3;22(21):5806-16.

21.

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.

Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honoré N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, de Thé H.

J Exp Med. 2001 Jun 18;193(12):1361-71.

22.

HPC3 is a new human polycomb orthologue that interacts and associates with RING1 and Bmi1 and has transcriptional repression properties.

Bárdos JI, Saurin AJ, Tissot C, Duprez E, Freemont PS.

J Biol Chem. 2000 Sep 15;275(37):28785-92.

23.
24.

JEM-1, a novel nuclear co-factor: localisation and functional interaction with AP-1.

Tong JH, Duprez E, Lanotte M.

Leukemia. 1999 Dec;13(12):1982-92.

25.

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.

Allford S, Grimwade D, Langabeer S, Duprez E, Saurin A, Chatters S, Walker H, Roberts P, Rogers J, Bain B, Patterson K, McKernan A, Freemont P, Solomon E, Burnett A, Goldstone A, Linch D.

Br J Haematol. 1999 Apr;105(1):198-207.

PMID:
10233384
26.

SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation.

Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, Solomon E, de Thé H, Hay RT, Freemont PS.

J Cell Sci. 1999 Feb;112 ( Pt 3):381-93.

27.

Expression patterns of the JEM-1 gene in normal and tumor cells: ubiquity contrasting with a faint, but retinoid-induced, mRNA expression in promyelocytic NB4 cells.

Tong JH, Fant X, Duprez E, Benoit G, Uphoff CC, Drexler HG, Pla JC, Lofvenberg E, Lanotte M.

Leukemia. 1998 Nov;12(11):1733-40.

28.

Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.

Cao T, Duprez E, Borden KL, Freemont PS, Etkin LD.

J Cell Sci. 1998 May;111 ( Pt 10):1319-29.

29.

Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.

Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F, Walker H, Culligan D, Waters J, Pomfret M, Goldstone A, Burnett A, Freemont P, Sheer D, Solomon E.

Blood. 1997 Dec 15;90(12):4876-85.

PMID:
9389704
30.

Surface residue mutations of the PML RING finger domain alter the formation of nuclear matrix-associated PML bodies.

Boddy MN, Duprez E, Borden KL, Freemont PS.

J Cell Sci. 1997 Sep;110 ( Pt 18):2197-205.

31.

JEM-1, a novel gene encoding a leucine-zipper nuclear factor upregulated during retinoid-induced maturation of NB4 promyelocytic leukaemia.

Duprez E, Tong JH, Dérré J, Chen SJ, Berger R, Chen Z, Lanotte M.

Oncogene. 1997 Apr 3;14(13):1563-70.

32.

The TEL gene products: nuclear phosphoproteins with DNA binding properties.

Poirel H, Oury C, Carron C, Duprez E, Laabi Y, Tsapis A, Romana SP, Mauchauffe M, Le Coniat M, Berger R, Ghysdael J, Bernard OA.

Oncogene. 1997 Jan 23;14(3):349-57.

35.

Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line.

Ruchaud S, Duprez E, Gendron MC, Houge G, Genieser HG, Jastorff B, Doskeland SO, Lanotte M.

Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8428-32.

36.

Antiapoptotic effect of heterozygously expressed mutant RI (Ala336-->Asp) subunit of cAMP kinase I in a rat leukemia cell line.

Duprez E, Gjertsen BT, Bernard O, Lanotte M, Døskeland SO.

J Biol Chem. 1993 Apr 15;268(11):8332-40.

37.

A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features.

Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner P, Berger R, Lanotte M.

Leukemia. 1992 Dec;6(12):1281-7.

PMID:
1453773

Supplemental Content

Loading ...
Support Center